Saturday, December 16, 2017 3:52:55 PM
Up until recently, I also believed that the company's ability to raise funds supported my believe the technology was promising. I now suspect the reason why the company was given the recent cash dealt instead with the warrant issue and the registration agreement which perhaps allows the warrant shares to be used for any purpose including shorting. I hope I am wrong but my faith in the company to date has been proven to be unwise.
What if the recent funding relates to a plan by someone to short the stock after the reverse split?
With regards to the recent Stonegate Capital report, following the reverse split the company stock would have to reach $38.00 to meet their target. Highly, highly unlikely. That would mean a market cap of 450 million which has happened only once before since I invested. When we hit $5.25 previously, I now believe it was a run up prior to a short, much like the 3 bucks per share before the suspected "Russell short."
My hope was for a similar run up prior to a short following the recent deals but I see no evidence it is presently needed by the "shorters." IMO our foolish management team has done the work for the "shorters" with the reverse split. At $2.20 per share there is plenty of money to be made if the stock is shorted back down to $.22.
As for the company not releasing needed information because they refraining from "pumping" the stock price, keeping shareholders advised of the actual results of a trial is not "pumping." Saying you are ready to hire a CFO when, if in fact, you have no intention to do so, could easily be described as "pumping as could any of the unfilled projections made by PN.
Why does the company fail to issue a press release regarding perhaps significant company events? To save money? I SUSPECT BPTH spent thousands of dollars in travel expenses for management to attend these investor meetings without prior nationwide PR releases (I saw) to the general public. Does this make sense? What was the result, a lower stock price?
It is has become my opinion that unless the company's actions benefit PN financially or helps him keep control of the company, BPTH is "pennywise and pound foolish." This opinion is based on my interpretation the reverse split information, my evaluation of PN's compensation and the company's repeated failures IMO to meet projected timelines.
The above post represents my opinion only and is based on many assumptions that may not be factually correct. This post is not intended as financial advice. Do your research and come to your own conclusions. Finally, I hope I am 100% wrong with this analysis and the company has a cure for cancer, which is why I invested here in the first place.
I am not going to comment on these issues any further for now but will instead wait for results.
Prove me wrong BPTH! I would like nothing better.
Recent BPTH News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 11:00:34 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 03/08/2024 10:11:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 12:10:34 PM
- Bio-Path Holdings Reports Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/08/2024 12:00:00 PM
- U.S. Index Futures Fluctuate Ahead of Key Jobs Report; Oil Prices Dip • IH Market News • 03/08/2024 11:22:25 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 09:21:27 PM
- Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024 • GlobeNewswire Inc. • 03/01/2024 12:00:00 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 02/29/2024 11:00:30 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 12:01:09 PM
- Bio-Path Holdings Announces 1-for-20 Reverse Stock Split • GlobeNewswire Inc. • 02/21/2024 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/02/2024 09:39:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:10:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 10:20:23 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/23/2024 09:51:03 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/17/2024 09:52:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:10:09 PM
- Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients • GlobeNewswire Inc. • 01/10/2024 12:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/04/2024 10:18:53 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/22/2023 09:06:16 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/22/2023 09:05:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 09:05:23 PM
- Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia • GlobeNewswire Inc. • 12/14/2023 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/08/2023 09:05:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:05:35 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM